Potential Drugs and Chemotherapeutants for Marine Shrimp Production: Selection, Evaluation, and Approval Processes, Year 05
July 1, 1991
|Hawaii||$100,788||University of Arizona, University of Hawaii at Manoa, Hawaii Aquaculture Development Program, and John Controulis, Ph.D., Inc||D.V. Lightner, R.R. Williams, R. Fujioka, J. Brock, and J. Controulis|
- Define significant disease problems of penaeid shrimp hatchery, nursery, grow-out, and/or broodstock rearing facilities, and in particular those diseases that appear to be potentially treatable.
- Identify and test likely drugs and/or chemotherapeutants for the treatment of disorders or syndromes previously defined (in #1 above) as potentially treatable. Additional criteria for the selection of candidate compounds will be: reported efficacy, industry-sponsor interest, and potential for government approval under current federal regulations.
- With contractual and financial cooperation from an industry sponsor(s), obtain approval for the selected compound(s) from the appropriate federal government agency.